Expression of P16 cell cycle inhibitor in human cord blood CD34+ expanded cells following co-culture with bone marrowderived mesenchymal stem cells

Hematology

Volumn 17, Issue 6, 2012, Pages 334-340

  Oodi, Arezoo ^a   Noruzinia, Mehrdad ^b   Roudkenar, Mehryar Habibi ^a   Nikougoftar, Mahin ^a   Soltanpour, Mohamad Soleiman ^c   Khorshidfar, Mona ^a   Amirizadeh, Naser ^a  

^a HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cord blood; Expansion; Mesenchymal stem cell; Methylation; P16

Indexed keywords

CD34 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FLT3 LIGAND; PROTEIN P16; SCATTER FACTOR; THROMBOPOIETIN;

ARTICLE; CELL EXPANSION; COCULTURE; CONTROLLED STUDY; DNA METHYLATION; EX VIVO STUDY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; UMBILICAL CORD BLOOD;

ANTIGENS, CD34; BONE MARROW CELLS; COCULTURE TECHNIQUES; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA METHYLATION; FETAL BLOOD; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC STEM CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; STROMAL CELLS;

EID: 84869750388     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/1607845412Y.0000000009     Document Type: Article

References (30)

1. Delaney C, Ratajczak MZ, Laughlin MJ. Strategies to enhance umbilical cord blood stem cell engraftment in adult patients. Expert Rev Hematol. 2010;3:273-83.
2. Hal E. Broxmeyer: umbilical cord transplantation: epilogue. Semin Hematol. 2010;47:97-103.
3. Wagner JE, Barker JN, DeFor TE, Baker KS, Blazar BR, Eide C, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611-8
4. Dahlberg A, Delaney C, Bernstein ID. Ex vivo expansion of human hematopoietic stem and progenitor cells. Blood. 2011; 23:234-45.
5. Conrad PD, Emerson SG. Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation. J Leukoc Biol. 1998;64:147-55
6. Miyata Y, Liu Y, Jankovic V, Sashida G, Lee JM, Shieh JH, et al. Cyclin C regulates human hematopoietic stem/progenitor cell quiescence. Stem Cells. 2010;28(2):308-17.
7. Reya T, Morrison SJ, Clarke MF, Weissman IL. Review article stem cells, cancer and cancer stem cells. Nature. 2001;414: 105-11.
8. Cheng T. Cell cycle inhibitors in normal and tumor stem cells. Oncogene. 2004;23:7256-66.
9. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclindependent kinases. Genes Dev. 1995;9:1149-63.
10. Quesnel B, Preudhomme C, Lepelley P, Hetuin D, Vanrumbeke M, Bauters F, et al. Transfer of p16inka/CDKN2 gene in leukaemic cell lines inhibits cell proliferation. Br J Haematol. 1996; 95(2):291-8.
11. Youichirou M, Toshiyuki S. INK4 Family - a promising target for 'gene-regulating chemoprevention' and 'molecular-targeting prevention' of cancer. Environ Health Prev Med. 2005;1:72-7.
12. Toshiyasu H, Phillip K. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood. 1995;86:841-54.
13. Nakamaki T, Kawamata N, Schwaller J, Tobler A, Fey M, Pakkala S, et al. Structural integrity of the cyclin-dependent kinase inhibitor genes, p15, p16 and p18 in myeloid leukaemias. Br J Haematol. 1995;91:139-49.
14. Ogawa S, Hangaishi A, Miyawaki S, Hirosawa S, Miura Y, Takeyama K, et al. Loss of the cyclin-dependent kinase 4-inhibitor (p16; MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood. 1995;86:1548-56.
15. Majumdar MK, Thiede MA, Haynesworth SE, Bruder SP, Gerson SL, et al. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res. 2000;9: 841-8.
16. James G, Herman T, Jeremy R, Nelkin BD, Baylin SB, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Med Sci. 1996:9821-6.
17. Xu X-L, Yu J, Zhang H-Y, Sun MH, Gu J, Du X, et al. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol. 2004;10:3441-54.
18. Pattyn F, Speleman F, De Paepe A, Vandesompele J, et al. The real-time PCR primer and probe database. Nucleic Acids Res. 2003;31:122-3.
19. Tung SS, Parmar S, Robinson SN, De Lima M, Shpall EJ. Ex vivo expansion of umbilical cord blood for transplantation. Best Pract Res Clin Haematol. 2010;23:245-57.
20. Yildirim S, Boehmler AM, Kanz L, Mohle R. Expansion of cord blood CD34+ hematopoietic progenitor cells in co-culture with autologous umbilical vein endothelial cells (HUVEC) is superior to cytokine-supplemented liquid culture. Bone Marrow Transplant. 2005;36:71-9.
21. Alvarado-Moreno A, Chávez-González A, Cérbulo A, Arriaga L, Mayani H, et al. In vitro cell cycle dynamics of primitive hematopoietic cells from human umbilical cord blood. Hematology. 2010;15:11-20.
22. Jang YK, Jung DH, Yang S-E, Kim DH, Yoo KH, Sung KW, et al. Mesenchymal stem cells feeder layer from human umbilical cord blood for ex vivo expanded growth and proliferation of hematopoietic progenitor cells. Ann Hematol. 2006;85:212-25.
23. Lewis JL, Chinswangwatanakul W, Zheng B, Marley SB, Nguyen DX, Cross NC, et al. The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells. Blood. 2001;97:2604-10.
24. Furukawa Y, Kikuchi J, Nakamura M, Iwase S, Yamada H, Matsuda M, et al. Lineage-specific regulation of cell cycle control gene expression during haematopoietic cell differentiation. Br J Haematol. 2000;110:663-73.
25. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet. 2006;7:21-33.
26. Belinsky SA, Nikula KJ, Palmisano WA, Michels R, Saccomanno G, Gabrielson E, et al. Aberrant methylation of p16 (INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci. 1998;95:11891-6.
27. McDermott KM, Zhang J, Holst CR, Kozakiewicz K, Singla V, Tlsty TD, et al. p16 (INK4a) prevents centrosome dysfunction and genomic instability in primary cells. PLoS Biol. 2006;4:e51.
28. Reynolds PA, Sigaroudinia M, Zardo G, Wilson MB, Benton GM, Miller CJ, et al. Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. J Biol Chem. 2006;281:24790-802.
29. Jones A, Baylin B. The epigenomics of Cancer. Cell. 2007;128: 683-92.
30. Sakashita K, Koike K, Kinoshita T, Shiohara M, Kamijo T, Taniguchi S, et al. Dynamic DNA methylation change in the CpG island region of p15 during human myeloid development. J Clin Invest. 2001;108:1195-204.